link.springer.com

Expression and clinicopathological significance of EED, SUZ12 and EZH2 mRNA in colorectal cancer - Journal of Cancer Research and Clinical Oncology

  • ️Yang, Yan-Mei
  • ️Sun Oct 19 2014

  • Balasubramanian S, Lee K, Adhikary G, Gopalakrishnan R, Rorke EA, Eckert RL (2008) The Bmi-1 polycomb group gene in skin cancer: regulation of function by (-)-epigallocatechin-3-gallate. Nutr Rev 66(Suppl 1):S65–S68. doi:10.1111/j.1753-4887.2008.00071.x

    Article  PubMed Central  PubMed  Google Scholar 

  • Brait M, Sidransky D (2011) Cancer epigenetics: above and beyond. Toxicol Mech Methods 21:275–288. doi:10.3109/15376516.2011.562671

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Bryant RJ, Cross NA, Eaton CL, Hamdy FC, Cunliffe VT (2007) EZH2 promotes proliferation and invasiveness of prostate cancer cells. Prostate 67:547–556. doi:10.1002/pros.20550

    Article  CAS  PubMed  Google Scholar 

  • Cao R, Zhang Y (2004) SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex. Mol Cell 15:57–67. doi:10.1016/j.molcel.2004.06.020

    Article  CAS  PubMed  Google Scholar 

  • Cao R et al (2002) Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science 298:1039–1043. doi:10.1126/science.1076997

    Article  CAS  PubMed  Google Scholar 

  • Cao W et al (2011) EZH2 promotes malignant phenotypes and is a predictor of oral cancer development in patients with oral leukoplakia. Cancer Prev Res 4:1816–1824. doi:10.1158/1940-6207.CAPR-11-0130

    Article  CAS  Google Scholar 

  • Cao W et al (2012) EZH2 promotes malignant behaviors via cell cycle dysregulation and its mRNA level associates with prognosis of patient with non-small cell lung cancer. PLoS ONE 7:e52984. doi:10.1371/journal.pone.0052984

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Cui B, Tao J, Yang Y (2012) Studies on the expression patterns of class I PI3K catalytic subunits and its prognostic significance in colorectal cancer. Cell Biochem Biophys 62:47–54. doi:10.1007/s12013-011-9257-6

    Article  CAS  PubMed  Google Scholar 

  • Cui Y, Chen J, He Z, Xiao Y (2013) SUZ12 depletion suppresses the proliferation of gastric cancer cells. Cell Physiol Biochem 31:778–784. doi:10.1159/000350095

    Article  CAS  PubMed  Google Scholar 

  • Denisenko O, Shnyreva M, Suzuki H, Bomsztyk K (1998) Point mutations in the WD40 domain of Eed block its interaction with Ezh2. Mol Cell Biol 18:5634–5642

    PubMed Central  CAS  PubMed  Google Scholar 

  • Eskander RN, Ji T, Huynh B, Wardeh R, Randall LM, Hoang B (2013) Inhibition of enhancer of zeste homolog 2 (EZH2) expression is associated with decreased tumor cell proliferation, migration, and invasion in endometrial cancer cell lines. Int J Gynecol Cancer 23:997–1005. doi:10.1097/IGC.0b013e318296a265

    Article  PubMed Central  PubMed  Google Scholar 

  • Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–2917. doi:10.1002/ijc.25516

    Article  CAS  PubMed  Google Scholar 

  • Fluge O et al (2009) Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis. Br J Cancer 101:1282–1289. doi:10.1038/sj.bjc.6605333

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Fussbroich B et al (2011) EZH2 depletion blocks the proliferation of colon cancer cells. PLoS ONE 6:e21651. doi:10.1371/journal.pone.0021651

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Gong Y et al (2011) Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcome. Cancer 117:5476–5484. doi:10.1002/cncr.26179

    Article  CAS  PubMed  Google Scholar 

  • Hammoud SS, Cairns BR, Jones DA (2013) Epigenetic regulation of colon cancer and intestinal stem cells. Curr Opin Cell Biol 25:177–183. doi:10.1016/j.ceb.2013.01.007

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Hu S et al (2010) Overexpression of EZH2 contributes to acquired cisplatin resistance in ovarian cancer cells in vitro and in vivo. Cancer Biol Ther 10:788–795

    Article  CAS  PubMed  Google Scholar 

  • Iliopoulos D, Lindahl-Allen M, Polytarchou C, Hirsch HA, Tsichlis PN, Struhl K (2010) Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells. Mol Cell 39:761–772. doi:10.1016/j.molcel.2010.08.013

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90. doi:10.3322/caac.20107

    Article  PubMed  Google Scholar 

  • Jones PA, Baylin SB (2007) The epigenomics of cancer. Cell 128:683–692. doi:10.1016/j.cell.2007.01.029

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Khare S, Verma M (2012) Epigenetics of colon cancer. Methods Mol Biol 863:177–185. doi:10.1007/978-1-61779-612-8_10

    Article  CAS  PubMed  Google Scholar 

  • Kim JH et al (2004) The Bmi-1 oncoprotein is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a/p14ARF proteins. Cancer Lett 203:217–224

    Article  CAS  PubMed  Google Scholar 

  • Kim W, Bird GH, Neff T, Guo G, Kerenyi MA, Walensky LD, Orkin SH (2013) Targeted disruption of the EZH2-EED complex inhibits EZH2-dependent cancer. Nat Chem Biol 9:643–650. doi:10.1038/nchembio.1331

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Kodach LL et al (2010) The role of EZH2 and DNA methylation in the silencing of the tumour suppressor RUNX3 in colorectal cancer. Carcinogenesis 31:1567–1575. doi:10.1093/carcin/bgq147

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Ku M et al (2008) Genomewide analysis of PRC1 and PRC2 occupancy identifies two classes of bivalent domains. PLoS Genet 4:e1000242. doi:10.1371/journal.pgen.1000242

    Article  PubMed Central  PubMed  Google Scholar 

  • Li DW et al (2010) Expression level of Bmi-1 oncoprotein is associated with progression and prognosis in colon cancer. J Cancer Res Clin Oncol 136:997–1006. doi:10.1007/s00432-009-0745-7

    Article  CAS  PubMed  Google Scholar 

  • Li H et al (2012) SUZ12 promotes human epithelial ovarian cancer by suppressing apoptosis via silencing HRK. Mol Cancer Res 10:1462–1472. doi:10.1158/1541-7786.MCR-12-0335

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Lin YW, Chen HM, Fang JY (2011) Gene silencing by the Polycomb group proteins and associations with cancer. Cancer Invest 29:187–195. doi:10.3109/07357907.2010.512605

    Article  CAS  PubMed  Google Scholar 

  • Liu C, Shi X, Wang L, Wu Y, Jin F, Bai C, Song Y (2014) SUZ12 is involved in progression of non-small cell lung cancer by promoting cell proliferation and metastasis. Tumour Biol 35:6073–6082. doi:10.1007/s13277-014-1804-5

    Article  CAS  PubMed  Google Scholar 

  • Martin-Perez D et al (2010) Deregulated expression of the polycomb-group protein SUZ12 target genes characterizes mantle cell lymphoma. Am J Pathol 177:930–942. doi:10.2353/ajpath.2010.090769

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Novak K (2004) Epigenetics changes in cancer cells. MedGenMed 6:17

    PubMed Central  PubMed  Google Scholar 

  • Pietersen AM et al (2008) EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer. Breast Cancer Res 10:R109. doi:10.1186/bcr2214

    Article  PubMed Central  PubMed  Google Scholar 

  • Piunti A, Pasini D (2011) Epigenetic factors in cancer development: polycomb group proteins. Future Oncol 7:57–75. doi:10.2217/fon.10.157

    Article  CAS  PubMed  Google Scholar 

  • Richly H, Aloia L, Di Croce L (2011) Roles of the Polycomb group proteins in stem cells and cancer. Cell Death Dis 2:e204. doi:10.1038/cddis.2011.84

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Rodenhiser DI (2009) Epigenetic contributions to cancer metastasis. Clin Exp Metastasis 26:5–18. doi:10.1007/s10585-008-9166-2

    Article  CAS  PubMed  Google Scholar 

  • Sato T et al (2013) PRC2 overexpression and PRC2-target gene repression relating to poorer prognosis in small cell lung cancer. Sci Rep 3:1911. doi:10.1038/srep01911

    PubMed Central  PubMed  Google Scholar 

  • Seo GS et al (2013) EED gene polymorphism in patients with colorectal cancer. Int J Biol Markers 28:274–279. doi:10.5301/JBM.5000024

    Article  CAS  PubMed  Google Scholar 

  • Sharma S, Kelly TK, Jones PA (2010) Epigenetics in cancer. Carcinogenesis 31:27–36. doi:10.1093/carcin/bgp220

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Shen L, Cui J, Liang S, Pang Y, Liu P (2013) Update of research on the role of EZH2 in cancer progression. Onco Targets Ther 6:321–324. doi:10.2147/OTT.S42453

    Article  PubMed Central  PubMed  Google Scholar 

  • Simon JA, Lange CA (2008) Roles of the EZH2 histone methyltransferase in cancer epigenetics. Mutat Res 647:21–29. doi:10.1016/j.mrfmmm.2008.07.010

    Article  CAS  PubMed  Google Scholar 

  • Sparmann A, van Lohuizen M (2006) Polycomb silencers control cell fate, development and cancer. Nat Rev Cancer 6:846–856. doi:10.1038/nrc1991

    Article  CAS  PubMed  Google Scholar 

  • Tan JZ, Yan Y, Wang XX, Jiang Y, Xu HE (2014) EZH2: biology, disease, and structure-based drug discovery. Acta Pharmacol Sin 35:161–174. doi:10.1038/aps.2013.161

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Wang CG, Ye YJ, Yuan J, Liu FF, Zhang H, Wang S (2010) EZH2 and STAT6 expression profiles are correlated with colorectal cancer stage and prognosis. World J Gastroenterol 16:2421–2427

    Article  PubMed Central  PubMed  Google Scholar 

  • Wang J, Ma ZB, Li K, Guo GH (2014) Association between EZH2 polymorphisms and colorectal cancer risk in Han Chinese population. Med Oncol 31:874. doi:10.1007/s12032-014-0874-y

    Article  PubMed  Google Scholar 

  • Wolters T, Vissers KJ, Bangma CH, Schroder FH, van Leenders GJ (2010) The value of EZH2, p27(kip1), BMI-1 and MIB-1 on biopsy specimens with low-risk prostate cancer in selecting men with significant prostate cancer at prostatectomy. BJU Int 106:280–286. doi:10.1111/j.1464-410X.2009.08998.x

    Article  PubMed  Google Scholar 

  • Yin T et al (2011) Bmi-1 promotes the chemoresistance, invasion and tumorigenesis of pancreatic cancer cells. Chemotherapy 57:488–496. doi:10.1159/000334103

    Article  CAS  PubMed  Google Scholar 

  • Yoo KH, Hennighausen L (2012) EZH2 methyltransferase and H3K27 methylation in breast cancer. Int J Biol Sci 8:59–65

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Yu H et al (2012) PRC2/EED-EZH2 complex is up-regulated in breast cancer lymph node metastasis compared to primary tumor and correlates with tumor proliferation in situ. PLoS ONE 7:e51239. doi:10.1371/journal.pone.0051239

    Article  PubMed Central  CAS  PubMed  Google Scholar